The DOI matches its Crossref record; 94 of the 95 references it cites were found in a registry or an index.
Agomelatine, a New Antidepressant, Induces Regional Changes in Hippocampal Neurogenesis
Abstract
Background Antidepressant treatments increase neural plasticity and adult neurogenesis, especially in the hippocampus. Here, we determined the effects of agomelatine (S-20098), a new antidepressant, on various phases of neurogenesis in the dentate gyrus of adult rat.Methods Animals were injected with agomelatine for different time periods. Immunostaining for bromodeoxyuridine, neuron specific nuclear protein, and glial fibrillary acid protein, as well as for the highly polysialylated form of neuronal cell adhesion molecule and doublecortin, was used to detect changes in cell proliferation, neurogenesis, and survival. Cell death was estimated by terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end labeling and cresyl violet staining.Results Chronic (3 weeks) but not acute (4 hours) or subchronic (1 week) administration of agomelatine increased cell proliferation and neurogenesis in the ventral dentate gyrus, a region notably implicated in response to emotion, which is consistent with the antidepressant-anxiolytic properties of the drug. Extending agomelatine treatment over several weeks, however, increases survival of newly formed neurons in the entire dentate gyrus. Finally, agomelatine treatment does not affect mature granule cells.Conclusions This study shows that an antidepressant can affect differentially various stages of neurogenesis in the dorsal and ventral hippocampus. Altogether, these changes lead to a pronounced augmentation in the total number of new granule cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, chronic, but not acute, treatment with agomelatine also induces neurogenesis in the hippocampus similar to other antidepressants (Banasr et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Banasr et al., 2006
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
More hippocampal neurons in adult mice living in an enriched environment
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1997) · Nature · doi:10.1038/386493a0 · Cited by 3,586
Kuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Hammen, C. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143938 · Cited by 2,979
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Neurogenesis in the adult is involved in the formation of trace memories
Shors, T. J., Miesegaes, G. R., Beylin, A. V., Zhao, M., Rydel, T. A., & Gould, E. (2001) · Nature · doi:10.1038/35066584 · Cited by 2,014
Research works printed but not linked: 3
- Bertaina-Anglade, 2002, Antidepressant-like action of S 20098 (agomelatine) in the learned helplessness test, Int J Neuropsychopharmacol, 5, S65
- Bourin, 2004, Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents, J Psychiatry Neurosci, 29, 126
- Loo, 2002, [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders], Encephale, 28, 356
Cited by
Sorted by citations
Items 101–200 of 318
Felice, D., O’Leary, O. F., Pizzo, R., & Cryan, J. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.066 · Cited by 70
Conboy, L., Tanrıkut, C., Zoladz, P. R., Campbell, A. M., Park, C. R., Gabriel, C., Mocaër, E., Sandi, C., & Diamond, D. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009255 · Cited by 67
Mocaër, E., Dagytė, G., Crescente, I., Postema, F., Seguin, L., Gabriel, C., den Boer, J. A., & Koolhaas, J. M. (2011) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(11)70669-1 · Cited by 65
Wu, M. V., Sahay, A., Duman, R. S., & Hen, R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018978 · Cited by 64
O’Leary, O. F., O’Connor, R. M., & Cryan, J. F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.015 · Cited by 65
Bortolotto, V., Cuccurazzu, B., Canonico, P. L., & Grilli, M. (2014) · BioMed Research International · doi:10.1155/2014/612798 · Cited by 67
Calabrese, F., Molteni, R., Gabriel, C., Mocaër, E., Racagni, G., & Riva, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2129-8 · Cited by 67
New Therapeutic Targets for Mood Disorders
Machado‐Vieira, R., Salvadore, G., Diazgranados, N., Ibrahim, L. A., Latov, D. R., Wheeler‐Castillo, C., Baumann, J., Henter, I. D., & Zarate, C. A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.65 · Cited by 64
Region- and phase-dependent effects of 5-HT1A and 5-HT2C receptor activation on adult neurogenesis
Soumier, A., Banasr, M., Goff, L. K., & Daszuta, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.007 · Cited by 64
Opendak, M., Offit, L., Monari, P., Schoenfeld, T. J., Sonti, A. N., Cameron, H. A., & Gould, E. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4435-15.2016 · Cited by 61
Patrício, P., Mateus-Pinheiro, A., Irmler, M., Alves, N. D., Machado-Santos, A. R., Morais, M., Correia, J. S., Korostynski, M., Piechota, M., Stoffel, R., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.176 · Cited by 57
Mahar, I., Tan, S., Davoli, M. A., Domínguez-López, S., Qiang, C., Rachalski, A., Turecki, G., & Mechawar, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026610 · Cited by 62
Anacker, C. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_275 · Cited by 63
Bétry, C., Etiévant, A., Pehrson, A., Sánchez, C., & Haddjeri, N. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.12.002 · Cited by 59
Guadagno, A., Kang, M. S., Devenyi, G. A., Mathieu, A. P., Rosa‐Neto, P., Chakravarty, M. M., & Walker, C. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1720-3 · Cited by 61
Chronic interleukin-1β in the dorsal hippocampus impairs behavioural pattern separation
Hueston, C. M., O’Leary, J. D., Hoban, A. E., Kozareva, D. A., Pawley, L. C., O’Leary, O. F., Cryan, J. F., & Nolan, Y. M. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.015 · Cited by 64
Barr, J. L., Renner, K. J., & Forster, G. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.011 · Cited by 59
Could agomelatine be the ideal antidepressant?
Pandi-Perumal, S. R., Srinivasan, V., Cardinali, D. P., & Monti, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.11.1595 · Cited by 60
Karabeg, M. M., Grauthoff, S., Kollert, S. Y., Weidner, M., Heiming, R. S., Jansen, F., Popp, S., Kaiser, S., Lesch, K.-P., Sachser, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078238 · Cited by 56
Bambico, F. R., & Belzung, C. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_234 · Cited by 61
Ryu, S., Kim, H. G., Kim, J. Y., Kim, S.-Y., & Cho, K. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4006 · Cited by 58
Sleep–wake changes and cognition in neurodegenerative disease
Naismith, S. L., Lewis, S. J. G., & Rogers, N. L. (2011) · Progress in brain research · doi:10.1016/b978-0-444-53817-8.00002-5 · Cited by 59
Role for the Clock Gene in Bipolar Disorder
McClung, C. A. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.031 · Cited by 57
Wainwright, S. R., Workman, J. L., Tehrani, A. R., Hamson, D. K., Chow, C., Lieblich, S. E., & Galea, L. A. M. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.001 · Cited by 57
Reducing central serotonin in adulthood promotes hippocampal neurogenesis
Song, N., Jia, Y., Zhang, L., Zhang, Q., Huang, Y., Liu, X., Hu, L., Lan, W., Chen, L., Lesch, K., et al. (2016) · Scientific Reports · doi:10.1038/srep20338 · Cited by 56
Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
Srinivasan, V., Zakaria, R., Othman, Z., Lauterbach, E. C., & Acuña-Castroviejo, D. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11090216 · Cited by 58
Ladurelle, N., Gabriel, C., Viggiano, A., Mocaër, E., Baulieu, E. E., & Bianchi, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2597-5 · Cited by 51
Foley, A., Hirst, W. D., Gallagher, H. C., Barry, C. E., Hagan, J. J., Upton, N., Walsh, F. S., HUNTER, A., & REGAN, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.012 · Cited by 52
Kaae, S. S., Chen, F., Wegener, G., Madsen, T. M., & Nyengaard, J. R. (2012) · Synapse · doi:10.1002/syn.21553 · Cited by 52
Region‐specific response of the hippocampus to chronic unpredictable stress
Hawley, D. F., & Leasure, J. L. (2011) · Hippocampus · doi:10.1002/hipo.20970 · Cited by 54
Harvey, B. H., Regenass, W., Dreyer, W., & Möller, M. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826783 · Cited by 50
The use of antidepressants in clinical practice: focus on agomelatine
McAllister-Williams, H., Baldwin, D. S., Haddad, P. M., & Bazire, S. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1094 · Cited by 49
Major depression: emerging therapeutics
Sen, S., & Sanacora, G. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20043 · Cited by 50
Anxiety-related activity of ventral hippocampal interneurons
Forro, T., Volitaki, E., Malagon‐Vina, H., Klausberger, T., Nevian, T., & Ciocchi, S. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102368 · Cited by 51
Abboussi, O., Tazi, A., Païzanis, E., & Ganouni, S. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.014 · Cited by 47
García-Fuster, M. J., Flagel, S. B., Mahmood, S. T., Mayo, L. M., Thompson, R. C., Watson, S. J., & Akil, H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.119 · Cited by 48
Martin, V., Allaïli, N., Euvrard, M., Marday, T., Riffaud, A., Franc, B., Mocaër, E., Gabriel, C., Fossati, P., Lehéricy, S., et al. (2017) · Scientific Reports · doi:10.1038/srep45907 · Cited by 46
Life-Long Hippocampal Neurogenesis: Environmental, Pharmacological and Neurochemical Modulations
Païzanis, E., Kelaï, S., Renoir, T., Hamon, M., & Lanfumey, L. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9330-0 · Cited by 49
Agomelatine, a melatonin agonist with antidepressant properties
Dubovsky, S. L., & Warren, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903292634 · Cited by 45
Herrera‐Arozamena, C., Martí‐Marí, O., Estrada, M., Revenga, M. D. L. F., & Rodrı́guez-Franco, M. I. (2016) · Molecules · doi:10.3390/molecules21091165 · Cited by 42
New neurons restore structural and behavioral abnormalities in a rat model of PTSD
Schoenfeld, T. J., Rhee, D., Martin, L., Smith, J. A., Sonti, A. N., Padmanaban, V., & Cameron, H. A. (2019) · Hippocampus · doi:10.1002/hipo.23087 · Cited by 43
Bipolar disorder: candidate drug targets
Zarate, C. A., & Manji, H. K. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20042 · Cited by 42
Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?
Hamon, M., & Bourgoin, S. (2006) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(06)70008-6 · Cited by 42
A novel 5HT3 receptor–IGF1 mechanism distinct from SSRI-induced antidepressant effects
Kondo, M., Koyama, Y., Nakamura, Y., & Shimada, S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.87 · Cited by 41
Dorsal Dentate Gyrus, a Key Regulator for Mood and Psychiatric Disorders
Sun, D., Mei, L., & Xiong, W. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.01.005 · Cited by 47
Ramírez-Rodríguez, G. B., Vega‐Rivera, N. M., Oikawa‐Sala, J., Gómez‐Sánchez, A., Ortíz‐López, L., & Estrada-Camarena, E. M. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12136 · Cited by 40
Siteneski, A., Olescowicz, G., Pazini, F. L., Camargo, A., Fraga, D. B., Brocardo, P. S., Gil‐Mohapel, J., Cunha, M. P., & Rodrigues, A. L. S. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02143-9 · Cited by 41
Zhang, T., Hong, J., Di, T., & Chen, L. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00101 · Cited by 39
Lan, T., Wu, Y., Zhang, Y., Li, S., Zhu, Z., Wang, L., Mao, X., Li, Y., Fan, C., Wang, W., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02479-x · Cited by 44
The preclinical discovery and development of agomelatine for the treatment of depression
Konstantakopoulos, G., Dimitrakopoulos, S., & Michalopoulou, P. G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1781087 · Cited by 40
Howland, R. H. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5453 · Cited by 38
Social regulation of adult neurogenesis in a eusocial mammal
Peragine, D. E., Simpson, J. A., Mooney, S. J., Lovern, M. B., & Holmes, M. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.044 · Cited by 37
Meneghini, V., Cuccurazzu, B., Bortolotto, V., Ramazzotti, V., Ubezio, F., Tzschentke, T., Canonico, P. L., & Grilli, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091520 · Cited by 37
Ruksee, N., Tongjaroenbuangam, W., Mahanam, T., & Govitrapong, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.011 · Cited by 36
Tchekalarova, J. D., Atanasova, D., Nenchovska, Z., Atanasova, M., Kortenska, L., Gesheva, R., & Lazarov, N. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.017 · Cited by 36
Bettio, L. E. B., Neis, V. B., Pazini, F. L., Brocardo, P. S., Patten, A. R., Gil‐Mohapel, J., Christie, B. R., & Rodrigues, A. L. S. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13172 · Cited by 38
Batailler, M., Chesneau, D., Derouet, L., Butruille, L., Segura, S., Cognié, J., Dupont, J., Pillon, D., & Migaud, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24381-4 · Cited by 35
Li, J., Chen, J., Ma, N., Yan, D., Wang, Y., Zhao, X., Zhang, Y., & Zhang, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.010 · Cited by 35
Christensen, T. T., Bisgaard, C. F., Nielsen, H. B., & Wiborg, O. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.016 · Cited by 35
Liu, Q., Yu, J. M., Mi, W., Mao‐Ying, Q., Yang, R., Wang, Y.-Q., & Wu, G.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.033 · Cited by 34
Agomelatine: The Novel Antidepressant
Sup, W. Y., 왕희령, & Bahk, W. (2014) · 대한정신약물학회지 · Cited by 34
Dagyte, G., Luiten, P. G., De Jager, T., Gabriel, C., Mocaër, E., Den Boer, J. A., & Van der Zee, E. A. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22697 · Cited by 32
Self-citationAntidepressants for neuro-regeneration: from depression to Alzheimer’s disease
Kim, H., Kim, W., & Kong, S.-Y. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0238-8 · Cited by 35
Regenass, W., Möller, M., & Harvey, B. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117735769 · Cited by 33
Galea, L. A. M., Roes, M., Dimech, C. J., Chow, C., Mahmoud, R., Lieblich, S. E., & Duarte‐Guterman, P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.030 · Cited by 33
Insomnia in Patients with Depression
Jindal, R. D. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00004 · Cited by 33
Luo, L., Deng, S., Yi, J., Zhou, S., She, Y., & Liu, B. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/4072658 · Cited by 33
Melatonin’s stimulatory effect on adult hippocampal neurogenesis in mice persists after ovariectomy
Crupi, R., Mazzon, E., Marino, A., Spada, G. L., Bramanti, P., Spina, E., & Cuzzocrea, S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00897.x · Cited by 32
Gualtieri, F., Armstrong, E. A., Longmoor, G., D’Eath, R. B., Sandilands, V., Boswell, T., & Smulders, T. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-43584-x · Cited by 31
Yau, S., Lee, T. H.-Y., Formolo, D. A., Lee, W.-L., Li, L. C.-K., Parco Ming-fai, S. I. U., & Chan, C. C. H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00470 · Cited by 34
Bortolotto, V., Bondi, H., Cuccurazzu, B., Rinaldi, M., Canonico, P. L., & Grilli, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01000 · Cited by 32
Nishii, A., Amemiya, S., Kubota, N., Nishijima, T., & Kita, I. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00235 · Cited by 33
Antidepressant effects of focused ultrasound induced blood-brain-barrier opening
Mooney, S. J., Nóbrega, J. N., LEVITT, A. J., & Hynynen, K. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.004 · Cited by 30
Buga, A.-M., Vintilescu, R., Bălşeanu, T. A., Pop, O. T., Streba, C. T., Toescu, E. C., & Popa‐Wagner, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039302 · Cited by 30
Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease
Shruster, A., & Offen, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.028 · Cited by 31
Rennie, K., Butte, M. D., Fréchette, M., & Pappas, B. A. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00502.x · Cited by 30
Murata, Y., Yanagihara, Y. T., Mori, M., Mine, K., & Enjoji, M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.054 · Cited by 29
Pinar, C., Yau, S., Sharp, Z., Shamei, A., Fontaine, C. J., Meconi, A., Lottenberg, C. P., & Christie, B. R. (2018) · Brain Plasticity · doi:10.3233/bpl-170052 · Cited by 28
Agomelatine and its therapeutic potential in the depressed patient
Kennedy, S. H., & Eisfeld, B. S. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a917 · Cited by 29
Therapeutic potential of agomelatine in epilepsy and epileptic complications
Vimala, P. V., Bhutada, P., & Patel, F. R. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.017 · Cited by 29
Michaëlsson, H., Andersson, M., Svensson, J., Karlsson, L., Ehn, J., Culley, G. R., Engström, A., Bergström, N., Savvidi, P., Kuhn, H. G., et al. (2018) · Acta Physiologica · doi:10.1111/apha.13211 · Cited by 31
Sidor, M. M., Amath, A., MacQUEEN, G. M., & Foster, J. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.060 · Cited by 27
AlAhmed, S. H., & Herbert, J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.008 · Cited by 28
Agomelatine strongly interacts with zwitterionic DPPC and charged DPPG membranes
Ergun, S., Demir, P., Uzbay, T. I., & Severcan, F. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.07.025 · Cited by 28
Bisgaard, C. F., Bak, S. Y., Christensen, T. T., Jensen, O. N., Enghild, J. J., & Wiborg, O. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112460110 · Cited by 27
Effect of agomelatine on adult hippocampus apoptosis and neurogenesis using the stress model of rats
Yücel, A., Yücel, N., Özkanlar, S., Polat, E., Kara, A., Özcan, H., & Güleç, M. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.02.007 · Cited by 27
Mahar, I., MacIsaac, A., Kim, J. J., Qiang, C., Davoli, M. A., Turecki, G., & Mechawar, N. (2016) · Scientific Reports · doi:10.1038/srep30467 · Cited by 26
Yang, D., Zhang, W., Padhiar, A. A., Yao, Y., Shi, Y., Zheng, T., Davis, K., Zhang, Y., Huang, M., Li, Y., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00109 · Cited by 26
Night shift hormone: How does melatonin affect depression?
Kholghi, G., Eskandari, M., Saadlou, M.-S. S. Q., Zarrindast, M., & Vaseghi, S. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113835 · Cited by 26
Norman, T. R., Cranston, I., Irons, J. A., Gabriel, C., Dekeyne, A., Millan, M. J., & Mocaër, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.010 · Cited by 26
Atanasova, D., Lazarov, N., Stoyanov, D. S., Spassov, R. H., Tonchev, A. B., & Tchekalarova, J. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108706 · Cited by 24
Yagi, S., Lee, A. J., Truter, N., & Galea, L. A. M. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00450-2 · Cited by 24
Özkay, Ü. D., Söztutar, E., Can, Ö. D., Üçel, U. İ., Öztürk, Y., & Ulupınar, E. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000153 · Cited by 23
Can, Ö. D., Üçel, U. İ., Özkay, Ü. D., & Ulupınar, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082461 · Cited by 23
New Therapeutic Strategy for Mood Disorders
Crupi, R., Marino, A., & Cuzzocrea, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200417 · Cited by 20
Shors, T. J., Tobόn, K., DiFeo, G., Durham, D. M., & Chang, H. Y. M. (2016) · Scientific Reports · doi:10.1038/srep18960 · Cited by 21
Smeraldi, E., & Delmonte, D. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.828690 · Cited by 22
Souza, L. C., Martynhak, B. J., Bassani, T. B., Turnes, J. D. M., Machado, M. M. F., Moura, E. L. R., Andreatini, R., & Vital, M. A. B. F. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.033 · Cited by 21
Mateus‐Pinheiro, A., Patrício, P., Alves, N. D., Martins‐Macedo, J., Caetano, I., Silveira‐Rosa, T., Araújo, B., Mateus‐Pinheiro, M., Silva‐Correia, J., Sardinha, V. M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01287-8 · Cited by 21
Adult neurogenesis pharmacology in neurological diseases and disorders
Taupin, P. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.2.311 · Cited by 21
Metadata
- Authors
- Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Institut de Recherches Internationales Servier (France) (FR)
- Corresponding author
- Daszuta, Annie
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 59
- Issue
- 11
- Pages
- 1087-1096
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1965355495
- Cited by
- 318
- References
- 95
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 4 · 2020: 10 · 2019: 14 · 2018: 23 · 2017: 12 · 2016: 21 · 2015: 13 · 2014: 27 · 2013: 17 · 2012: 20
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- agomelatine, antidepressants, adult hippocampal neurogenesis, dentate gyrus, cell proliferation, neuronal survival, granule cells, neuroplasticity, chronic drug administration
- MeSH terms
- Acetamides, Doublecortin Domain Proteins, Doublecortin Protein, Animals, Bromodeoxyuridine, Cell Count, Cell Survival, Fluorescent Antibody Technique, Glial Fibrillary Acidic Protein, Hippocampus, Hypnotics and Sedatives, Male, Microtubule-Associated Proteins, Naphthalenes, Neurons, Neuropeptides, Nuclear Proteins, Time Factors, Cell Death, Rats, Wistar, Dentate Gyrus, Neural Cell Adhesion Molecule L1, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review